An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients

Status Completed

Clinical Trial Summary

The purpose of this study is to determine whether eculizumab long-term use is safe and effective in patients with relapsing NMO.

Clinical Trial Description

This study is an open label extension study to confirm the long term safety and efficacy of eculizumab in subjects with relapsing NMO who have completed the initial double-blind, randomized, placebo-controlled trial ECU-NMO-301. ;

Study Design

Related Conditions & MeSH terms

Neuromyelitis Optica
Neuromyelitis Optica Spectrum Disorder

Clinical Trial Details

NCT number	NCT02003144
Study type	Interventional
Source	Alexion Pharmaceuticals
Contact
Status	Completed
Phase	Phase 3
Start date	January 12, 2015
Completion date	July 12, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02283671` - Treatment of Multiple Sclerosis and Neuromyelitis Optica With Regulatory Dendritic Cell: Clinical Trial Phase 1 B	Phase 1
Recruiting	`NCT01024985` - Evaluation of Neural Loss in Multiple Sclerosis and Neuromyelitis Optica Using High Resolution Oct	N/A
Recruiting	`NCT04601142` - Association Between the Effect of Glucocorticoid Pulse Therapy on Neuromyelitis Optica (NMO) and Gene Polymorphism
Completed	`NCT03942952` - PEDIATRIC SONICS: Pediatric Study of Neuropsychology and Imaging in CNS Demyelinating Syndromes.
Recruiting	`NCT05573711` - Restless Legs Syndrome in People With Neuromyelitis Optica Spectrum Disorder
Not yet recruiting	`NCT06118398` - Efgartigimod in Acute Neuromyelitis Optica Spectrum Disorders
Recruiting	`NCT05566769` - Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD	N/A
Withdrawn	`NCT03829566` - Autologous Transplant To End NMO Spectrum Disorder	Phase 2/Phase 3
Recruiting	`NCT05403138` - Safety and Efficacy of Daratumumab in Patients With Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorders	Phase 2/Phase 3
Completed	`NCT03350633` - Tocilizumab vs Azathioprine in Neuromyelitis Optica Spectrum Disorders	Phase 2/Phase 3
Recruiting	`NCT05356858` - An Open Label Study of the Effects and Safety of Zanubrutinib in NMOSDs Adult Patients	Phase 2
Recruiting	`NCT05982925` - Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders
Active, not recruiting	`NCT00445367` - Biobank For MS And Other Demyelinating Diseases
Terminated	`NCT02398994` - A Multicentre randomiSed Controlled TRial of IntraVEnous Immunoglobulin Versus Standard Therapy for Transverse Myelitis	Phase 3
Withdrawn	`NCT02087813` - Pilot Study of alpha1-antitrypsin to Treat Neuromyelitis Optica Relapses	Phase 1
Terminated	`NCT01339455` - Autologous Hematopoietic Stem Cell Transplant in Neuromyelitis Optica	Phase 1/Phase 2
Recruiting	`NCT02021825` - Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders	Phase 4
Active, not recruiting	`NCT04614454` - High Frequency Impulse Therapy for Neuropathic Pain in NMOSD	Phase 2
Recruiting	`NCT03370965` - Optic Neuritis Differential Diagnosis Study	N/A
Completed	`NCT01777412` - Efficacy of Bevacizumab (Avastin) in Treatment of Acute NMO Exacerbations	Phase 1